Skin Diseases Treatment Industry Data Book | Forecast 2030
Skin Diseases Treatment Industry Data Book - Acne, Actinic Keratosis, Atopic Dermatitis, Alopecia Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030
Grand View Research’s skin diseases treatment industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research. The following data points will be included in the final product offering in five reports and one sector report overview.
Access the Global Skin Diseases Treatment Industry Data Book, 2023 to 2030, compiled with details like market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analyses studies.
Actinic Keratosis Treatment Market Report Highlights
The global actinic keratosis treatment market size is anticipated to reach USD 8.93 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.1% from 2022 to 2030.
- In 2021, the surgery segment dominated the market owing to the rising adoption of cryotherapy surgery in the management of actinic keratosis
- The nucleoside metabolic inhibitor segment held the largest share in 2021 and is expected to retain its dominance over the forecast period
- Asia Pacific is expected to register the highest CAGR over the forecast period due to factors such as the high prevalence of AK, rapidly evolving healthcare infrastructure, and rising healthcare expenditures by Asia Pacific countries
- North America dominated in 2021 due to the rising awareness among people about actinic keratosis, availability of robust treatment options, and improvements in healthcare infrastructure
Atopic Dermatitis Drugs Market Report Highlights
The global atopic dermatitis drugs market size is expected to reach USD 27.68 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.0% from 2022 to 2030.
- In 2021, biologics dominated the market owing to their higher demand and rising biologicsapprovals
- The injectable route of administration segment held the largest share in 2021 and is likely to maintain its dominance throughout the forecast period
- Europe is expected to register a significant CAGR in the forecast period owing to factors such as rising awareness among the population about skin conditions such as atopic dermatitis and the presence of a favorable regulatory framework
- North America dominated the market in 2021 due to the presence of leading market players, increased prevalence of atopic dermatitis, and increased research activities within the region
Order your copy of the Free Sample of “Skin Diseases Treatment Industry Data Book - Acne, Actinic Keratosis, Atopic Dermatitis, Alopecia Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030” Data Book, published by Grand View Research
Alopecia Market Report Highlights
The global alopecia market size is expected to reach USD 14.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.1% from 2021 to 2028.
- In 2020, the alopecia areata segment accounted for the largest revenue share and is anticipated to maintain its dominance over the forecast period
- Key late-stage pipeline candidates in the treatment of hair loss include: Xeljanz (tofacitinib), Breezula (clascoterone), and SM04554 are expected to fuel the growth in the coming years
- Alopecia universalis is anticipated to witness the fastest growth during the forecast period owing to the potential pipeline products, such as BNZ-1 (Bioniz Therapeutics), and stem cell educator therapy with minoxidil (Tianhe Stem Cell Biotechnologies, Inc.)
- North America was the largest market in 2020 mainly due to a high disease prevalence, rising consumer awareness, proactive government measures, technological advancements, and improved healthcare infrastructure
Acne Drugs Market Report Highlights
The global acne drugs market size is expected to reach USD 5.9 billion by 2025, according to a new report by Grand View Research, Inc., registering a 4.2% CAGR during the forecast period.
- By type, inflammatory acne captured more than 50.0% of the market in 2017. Comedonal acne were ranked second-largest, among other types
- On the basis of therapeutic class, retinoids led the market in 2017, followed by antibiotics. This trend is likely to continue through 2025
- The treatment paradigm is shifting toward combination therapies and biologics. Combination products are gaining traction due to higher efficacy, convenient dosing, and fewer adverse effects
- Topical products dominated the treatment landscape, based on mode of administration. However, introduction of biologics is likely to result in the growth of the injectables segment
- S. dominated the major markets and is projected to maintain its lead through 2025, owing to rising disease incidence and ease of access to anti-acne products
Go through the table of content of Skin Diseases Treatment Industry Data Book to get a better understanding of the Coverage & Scope of the study
Competitive Landscape
Key players operating in the skin diseases treatment industry are –
- Novartis AG
- AbbVie, Inc.
- Amgen Inc.
- Johnson & Johnson Services Inc.
- Leo Pharma A/S.
- Sun Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- GSK plc
- AstraZeneca
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc
- UCB S.A.
Grand View Research’s Skin Diseases Treatment Industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.
Check out more Industry Data Books, published by Grand View Research
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
